BioPharmSignal logoBioPharmSignal

Biotech News

Integra LifeSciences Announces Leadership Transition

Integra LifeSciences (IART)Integra LifeSciencesCommercial

Stuart Essig Appointed as Integra’s Next President and Chief Executive Officer Michael McBreen Appointed Chief Commercial Officer PRINCETON, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ: IART), a leading global medical

Open original release

Related news

IARTIntegra LifeSciences2026-06-02 11:30 EST

Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference

IARTIntegra LifeSciences2026-05-08 12:00 EST

Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference

ADPTAdaptive Biotechnologies2026-05-29 11:30 EST

At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research

CVRXCVRx2026-05-14 12:00 EST

CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy

XTNTXtant Medical2026-05-06 12:00 EST

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

STIMNeuronetics2026-04-29 20:30 EST

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

OMOutset Medical2026-04-06 20:05 EST

Outset Medical Names Derick Elliott as Executive Vice President of Commercial

XAIRBeyond Air2026-03-26 20:05 EST

Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO

RXSTRxSight2026-04-08 20:05 EST

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

ICCMIceCure Medical2026-07-14 12:32 EST

IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation

View all latest news

Integra LifeSciences

Integra LifeSciences is a medical technology company focused on regenerative tissue technologies, neurosurgery, and surgical instrumentation. Its business is centered on hospital and procedure-linked products.

Recent company news

IARTIntegra LifeSciences2026-06-02 11:30 EST

Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference

IARTIntegra LifeSciences2026-05-08 12:00 EST

Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference

IARTIntegra LifeSciences2026-05-05 10:00 EST

Integra LifeSciences Reports First Quarter 2026 Financial Results

IARTIntegra LifeSciences2026-05-05 10:00 EST

Integra LifeSciences Announces Leadership Transition

IARTIntegra LifeSciences2026-04-20 12:32 EST

Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026

Stock data

Close
19.53 USD
Market cap
1.22B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States